Showing 301 - 320 results of 675 for search '"combination therapy"', query time: 0.08s Refine Results
  1. 301

    Hepatitis in Disseminated Bacillus Calmette-Guérin Infection by Markus U Göttke, Philip Wong, Channy Muhn, Mansour Jabbari, Suzanne Morin

    Published 2000-01-01
    “…Empirical treatment was started with antituberculous combination therapy. A short course of an oral corticosteroid was given. …”
    Get full text
    Article
  2. 302

    Prognostic impact of primary versus secondary resistance to sorafenib in patients with HCC by Jin Lei, Hongyuan Dai, Ya Zhang, Guangling Ou, Zhi Peng Liang, Yinying Lu, Haiyang Li

    Published 2025-01-01
    “…Compared with tyrosine kinase inhibitor (TKI) monotherapy, the use of TKI plus PD-1 inhibitor combination therapy as second-line treatment conferred a longer median PFS (6.0 vs 10.0 months, p  < 0.001) and OS (13.0 vs 22.0 months, p  < 0.001). …”
    Get full text
    Article
  3. 303

    Management of asynchronous multifocal adult glioblastoma with loss of BRAFV600E -mutant clonality: a case report by Hannah Haile, Pavan S. Upadhyayula, Esma Karlovich, Michael B. Sisti, Brian J. A. Gill, Laura E. Donovan

    Published 2025-01-01
    “…Subsequent recurrences were managed with re-resection and dabrafenib/trametinib combination therapy. Notably, a new, non-clonal BRAFV600E -negative tumor developed in a distant location, highlighting the challenge of clonal evolution and resistance in GBM management. …”
    Get full text
    Article
  4. 304

    Regenerative Medicine for Neurological Disorders by Dong-Hyuk Park, David J. Eve, Yong-Gu Chung, Paul R. Sanberg

    Published 2010-01-01
    “…A number of studies focused on novel methods for drug monitoring or graft tracking, and combination therapy with stem cells and medicine, such as cytokines or trophic factors. …”
    Get full text
    Article
  5. 305

    Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells by Séin O'Connell, Craig Slattery, Michael P. Ryan, Tara McMorrow

    Published 2012-01-01
    “…These synergistic alterations may have been due to an increase in CTGF which was not evident when the immunosuppressive drugs were used alone. The CsA/SRL combination therapy significantly enhanced Smad signalling and altered the extracellular matrix regulator matrix metalloproteinase 9 (MMP-9). …”
    Get full text
    Article
  6. 306

    Pulmonary and Meningeal Cryptococcosis after Corticosteroid Therapy for Autoimmune Hepatitis: Coexistence of Cryptococci within Pulmonary Cancer Nodule by Takashi Yuri, Ayako Kimura, Katsuhiko Yoshizawa, Yuko Emoto, Yuichi Kinoshita, Airo Tsubura

    Published 2013-01-01
    “…Cryptococcal meningitis was diagnosed as positive for cryptococcal antigen from both serum and cerebrospinal fluid (CSF) as well as the growth of Cryptococcus neoformans (C. neoformans) in fungal culture. A combination therapy of amphotericin B and flucytosine was started, and the corticosteroid therapy was gradually reduced and finally discontinued. …”
    Get full text
    Article
  7. 307

    Association of Serum CXCL13 with Intrarenal Ectopic Lymphoid Tissue Formation in Lupus Nephritis by De Ning He, Wen Li Chen, Kang Xia Long, Xiao Zhang, Guang Fu Dong

    Published 2016-01-01
    “…LN patients with positive CD20 expression (CD20+ LN) had a longer disease course and poorer response to combination therapy and higher serum CXCL13 levels than CD20− LN patients. …”
    Get full text
    Article
  8. 308

    Clinical efficacy of different methods for treatment of granulomatous lobular mastitis: A systematic review and network meta-analysis. by Yuxiang Zhou, Leilai Xu

    Published 2025-01-01
    “…<h4>Conclusions</h4>Steroid-based combination therapy may be the first choice for IGM patients, with a comprehensive strategy of local and systemic steroids combined with surgery having the best effect on IGM.…”
    Get full text
    Article
  9. 309

    Features of conservative therapy of benign prostatic hyperplasia in patients with metabolic syndrome: " Treat to Target " by V. B. Filimonov, P. V. Vasin, V. N. Panchenko

    Published 2020-12-01
    “…A direct correlation was established between the severity of metabolic disorders and the progression of BPH /LUTS in the main assessed indicators. The use of combination therapy with metformin, ACE inhibitors / ARA and statins in combination with tamsulosin showed efficacy after 6 and 12 months of the study compared with tamsulosin monotherapy. …”
    Get full text
    Article
  10. 310

    Hotspots evolution and frontiers of immunotherapy for the treatment of acute myeloid leukemia: A bibliometric analysis by Nana Zhe, Qiang Li, Nanqu Huang, Hang Li, Hongyun Chen, Pinwei Zhu

    Published 2025-12-01
    “…The current research hotspots of AML immunotherapy included chimeric antigen receptor-T-cell therapy, antibody-based immunotherapies, immune checkpoint blockade, and combination therapy, highlighting the key aspects of immunotherapy for AML treatment and providing comprehensive insights into the research status and advances in this field. …”
    Get full text
    Article
  11. 311

    ALLERGIC RHINITICAL THERAPY WITH ACUPUNCTURE, LEGUNDI AND TEMULAWAK HERBS by Maya Septriana, Novita Purnamasari, Herra Studiawan

    Published 2019-01-01
    “…Purpose: To prove the effect of acupuncture combination therapy on Yintang point (EXHN 3), Yinxiang (LI 20), Zusanli (ST 36), Taibai (SP 3) with herbal legundi (Vitex trifolia) and temulawak (Curcuma xanthorrhiza) in patients with allergic rhinitis. …”
    Get full text
    Article
  12. 312
  13. 313

    ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma by Saffron E. Summers, Saffron E. Summers, Vehid Salih, Andrew D. Foey

    Published 2023-03-01
    “…Potential strategies including combination therapy, utilising both TAA-targeting CAR-Ts and immune checkpoint inhibitors, such as PD-L1, have been discussed, in an attempt to develop synergistic anti-tumour responses. …”
    Get full text
    Article
  14. 314

    In Vivo and In Vitro Studies Assessing the Antiviral Efficacy of Double Combinations Against Coxsackievirus B Infection by Adelina Stoyanova, Simeon Galabov, Vadim Makarov, Angel S. Galabov

    Published 2025-01-01
    “…Drug therapy is an important tool for controlling enterovirus infections, but clinically effective drugs do not currently exist, mainly due to the development of drug resistance. Combination therapy with two or more drugs has the potential to successfully inhibit viral infection more effectively than either drug alone as well as delay the development of resistance. …”
    Get full text
    Article
  15. 315

    Brucellosis Presenting with Febrile Pancytopenia: An Atypical Presentation of a Common Disease and Review of Brucellosis by Carina Chang, Bryce D. Beutler, Mark B. Ulanja, Chukwudum Uche, Milan Zdrnja

    Published 2021-01-01
    “…Treatment involves a prolonged course of multiple antibiotics; six weeks of combination therapy with aminoglycoside or rifampin and tetracycline represents the most common regimen. …”
    Get full text
    Article
  16. 316

    Targeting the kynurenine pathway: another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells by Irene Kang, Irene Kang, George Theodoropoulos, Medhi Wangpaichitr, Medhi Wangpaichitr, Medhi Wangpaichitr, Medhi Wangpaichitr

    Published 2025-01-01
    “…In Phase III investigation of the combination of IDO1 inhibition with immune checkpoint inhibitors (ICIs), the combination therapy was not efficacious. In this review, we revisit current advances, explore future directions, and emphasize the importance of dual inhibition of the KP rate-limiting enzymes IDO1 and tryptophan 2,3-dioxygenase-2 (TDO2) in appropriate patient populations. …”
    Get full text
    Article
  17. 317

    Antibacterial action of penicillin against Mycobacterium avium complex by D. Deshpande, G. Magombedze, S. Srivastava, T. Gumbo

    Published 2024-08-01
    “…CONCLUSIONS: Benzylpenicillin demonstrated a better bactericidal effect against MAC than guideline-recommended drugs before the development of resistance. Its role in combination therapy with other drugs with better efficacy than guideline-recommended drugs should be explored.…”
    Get full text
    Article
  18. 318

    MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment by Kouji Banno, Miho Iida, Megumi Yanokura, Iori Kisu, Takashi Iwata, Eiichiro Tominaga, Kyoko Tanaka, Daisuke Aoki

    Published 2014-01-01
    “…Previous approaches to development of siRNA as a drug have provided information for establishment of therapy based on these approaches, and an anti-miR-21 inhibitor has been developed. miRNAs also have effects on drug resistance and may be useful in combination therapy with other drugs.…”
    Get full text
    Article
  19. 319

    Conductive Composite Biosensor System for Electrochemical Indinavir Drug Detection by Natasha Ross, Nicolette Hendricks-Leukes, Rachel Fanelwa Ajayi, Priscilla Baker, Emmanuel I. Iwuoha

    Published 2015-01-01
    “…Indinavir undergoes first-pass metabolism through the cytochrome P450 (CYP) enzymes in the human liver, of which CYP3A4 is the most influential isoenzyme. Multidrug combination therapy and, as such, therapeutic drug monitoring (TDM) during HIV/AIDS treatment are therefore critical, to prevent adverse interactions. …”
    Get full text
    Article
  20. 320

    Surgical Excision and Radiotherapy for Giant Keloids in Auricula: A Case Report by Boesoirie SF, Winastuti RA, Permana AD, Yudistira NA, Gatera VA, Boesoirie MT

    Published 2025-01-01
    “…Therefore, this study aimed to report combination therapy for patients with giant keloids in auricula. …”
    Get full text
    Article